Clinical Trial Update: A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

View source ↗

Summary

The NOMAD study at Mayo Clinic is evaluating a novel blood DNA screening approach for cancer, currently recruiting to assess test specificity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies
• Solid Tumors

Snippet

Sponsor: Mayo Clinic | Conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm | Status: RECRUITING